Quadrant Capital Group’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.24M | Buy |
12,785
+3,976
| +45% | +$408K | 0.04% | 473 |
|
|
2025
Q4 | $935K | Buy |
8,809
+17
| +0.2% | +$1.97K | 0.03% | 589 |
|
|
2025
Q3 | $1.12M | Sell |
8,792
-33
| -0.4% | -$3.93K | 0.04% | 457 |
|
|
2025
Q2 | $1.08M | Buy |
8,825
+4,738
| +116% | +$541K | 0.04% | 434 |
|
|
2025
Q1 | $414K | Buy |
4,087
+3,701
| +959% | +$361K | 0.02% | 874 |
|
|
2024
Q4 | $35.6K | Sell |
386
-30
| -7% | -$2.94K | ﹤0.01% | 1600 |
|
|
2024
Q3 | $40.2K | Buy |
416
+90
| +28% | +$8.09K | ﹤0.01% | 1560 |
|
|
2024
Q2 | $28K | Buy |
326
+108
| +50% | +$9.06K | ﹤0.01% | 1707 |
|
|
2024
Q1 | $18K | Hold |
218
| – | – | ﹤0.01% | 1893 |
|
|
2023
Q4 | $14.5K | Sell |
218
-1
| -0.5% | -$65 | ﹤0.01% | 1930 |
|
|
2023
Q3 | $14.7K | Buy |
219
+17
| +8% | +$1.17K | ﹤0.01% | 1837 |
|
|
2023
Q2 | $13.7K | Sell |
202
-15
| -7% | -$940 | ﹤0.01% | 1894 |
|
|
2023
Q1 | $11.7K | Sell |
217
-214
| -50% | -$12.5K | ﹤0.01% | 1958 |
|
|
2022
Q4 | $25.8K | Buy |
431
+337
| +359% | +$18.3K | ﹤0.01% | 1528 |
|
|
2022
Q3 | $4K | Sell |
94
-82
| -47% | -$4.1K | ﹤0.01% | 2198 |
|
|
2022
Q2 | $8K | Sell |
176
-217
| -55% | -$11.1K | ﹤0.01% | 1770 |
|
|
2022
Q1 | $22K | Buy |
393
+207
| +111% | +$10.8K | ﹤0.01% | 1278 |
|
|
2021
Q4 | $10K | Sell |
186
-57
| -23% | -$2.94K | ﹤0.01% | 1621 |
|
|
2021
Q3 | $14K | Buy |
243
+51
| +27% | +$3.21K | ﹤0.01% | 1420 |
|
|
2021
Q2 | $12K | Sell |
192
-193
| -50% | -$12.9K | ﹤0.01% | 1473 |
|
|
2021
Q1 | $25K | Sell |
385
-16
| -4% | -$1.04K | ﹤0.01% | 1081 |
|
|
2020
Q4 | $26K | Buy |
401
+230
| +135% | +$13.5K | ﹤0.01% | 992 |
|
|
2020
Q3 | $9K | Buy |
171
+35
| +26% | +$1.8K | ﹤0.01% | 1270 |
|
|
2020
Q2 | $7K | Sell |
136
-1,936
| -93% | -$104K | ﹤0.01% | 1480 |
|
|
2020
Q1 | $106K | Buy |
2,072
+52
| +3% | +$3K | 0.02% | 562 |
|
|
2019
Q4 | $109K | Buy |
2,020
+79
| +4% | +$4.29K | 0.01% | 924 |
|
|
2019
Q3 | $96K | Buy |
1,941
+781
| +67% | +$39.2K | 0.01% | 900 |
|
|
2019
Q2 | $56K | Sell |
1,160
-35
| -3% | -$1.7K | 0.01% | 1166 |
|
|
2019
Q1 | $54K | Buy |
1,195
+1,143
| +2,198% | +$57.9K | 0.01% | 1168 |
|
|
2018
Q4 | $2K | Sell |
52
-7
| -12% | -$398 | ﹤0.01% | 1876 |
|
|
2018
Q3 | $3K | Buy |
59
+7
| +13% | +$426 | ﹤0.01% | 1707 |
|
|
2018
Q2 | $2K | Hold |
52
| – | – | ﹤0.01% | 1849 |
|
|
2018
Q1 | $2K | Hold |
52
| – | – | ﹤0.01% | 1823 |
|
|
2017
Q4 | $2K | Hold |
52
| – | – | ﹤0.01% | 1763 |
|
|
2017
Q3 | $1K | Buy |
+52
| New | +$1.85K | ﹤0.01% | 1945 |
|
|
2016
Q2 | – | Sell |
-55
| Closed | -$1K | – | 1999 |
|
|
2016
Q1 | $1K | Hold |
55
| – | – | ﹤0.01% | 1486 |
|
|
2015
Q4 | $1K | Sell |
55
-234
| -81% | -$6.66K | ﹤0.01% | 1444 |
|
|
2015
Q3 | $8K | Hold |
289
| – | – | 0.01% | 721 |
|
|
2015
Q2 | $10K | Buy |
+289
| New | +$10.3K | 0.01% | 699 |
|
Other funds holding EHC
VPM
VCM
Quadrant Capital Group's EHC Position: Q1 2026 in Review
Quadrant Capital Group increased its Encompass Health (EHC) stake by 45% in Q1 2026, buying an estimated $408K and bringing the position to 12,785 shares worth $1.24M. The position accounts for 0.04% of the portfolio, ranked #473.
Quadrant Capital Group first reported a position in EHC in Q2 2015 and has held it in 39 quarters since. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- Quadrant Capital Group held 12,785 shares of Encompass Health worth $1.24M as of Q1 2026.
- Quadrant Capital Group bought 3,976 Encompass Health shares in Q1 2026, an estimated $408K.
- Encompass Health made up 0.04% of Quadrant Capital Group's portfolio in Q1 2026, its #473 holding.
- Quadrant Capital Group first reported a position in Encompass Health in Q2 2015 and has held it in 39 quarters since.
- 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.